Programme by Interest

Healthcare data - Safeguarding confidentiality

Tuesday 3rd of September 2013
B2, 3 hours

Organised by the FIP Hospital Pharmacy Section and the FIP Pharmacy Information Section

Health professionals, including pharmacists, have increasing need for access to patient data for clinical review of complex patients. In parallel there are social changes which are tending to restrict access to patient data. This session is intended to explore the legal and ethics relating to the issue and give participants pointers to help their own practice.

Learning objectives

At the conclusion of the session, participants will be able to:
-    Describe the ethics relating to confidentiality of personal health data
-    Appreciate examples of legislation introduced internationally covering confidentiality
-    Translate the significance of confidentiality of data to pharmacy practice in own scenario.
-    Apply learning from this session to own practice.

Chairs: Yasuo Takeda (FIP HPS, Japan) and Lindsay McClure (FIP PIS, United Kingdom)


1) “HIPPA” – The Health Insurance Portability and Privacy Act in the USA
James Stevenson (FIP HPS, USA)

2) A European perspective
Clare Harney (Health Information and Quality Authority, Ireland)


3) Electronic data - Help or hindrance to confidentiality?
Betty Chaar (University of Sydney, Australia)

4) What is happening to aid pharmacists’ access to data?
Stephen Goundry-Smith (Royal Pharmaceutical Society, United Kingdom)